Overview

This nonrandomized controlled trial was part of the National Research Program Smarter Health Care, launched by the Swiss National Science Foundation to promote innovative health services research and to tackle practical challenges of caring for patients with multimorbidity in Switzerland.²⁰ As a quality improvement study, the institutional review board of Northwestern Switzerland approved the study and waived the need for individual informed consent by formulating a declaration of no objection. Eligible patients were informed by clinical staff and an information flyer about their study participation within 24 hours after hospital admission. This study follows the Transparent Reporting of Evaluations with Nonrandomized Designs (TREND) reporting guideline.²¹